...
search icon
ogen-img

Oragenics Inc, Common Stock

OGEN

ASQ

$0.343

+$0.01

(3%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$4.32M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
377.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.48
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.25 L
$6.22 H
$0.343

About Oragenics Inc, Common Stock

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameOGENSectorS&P500
1-Week Return-0.52%0.49%-0.42%
1-Month Return-6.89%-3.1%-2.2%
3-Month Return-11.37%-8.59%2.38%
6-Month Return-70.93%-4.57%5.1%
1-Year Return-94.03%-0.94%23.79%
3-Year Return-98.85%2.88%26.66%
5-Year Return-98.81%35.84%81.16%
10-Year Return-99.93%98.8%191.72%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue--86.99K131.52K37.65K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":66.14,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.63,"profit":true}]
Cost of Revenue62.62K51.70K41.24K44.67K15.49M[{"date":"2019-12-31","value":0.4,"profit":true},{"date":"2020-12-31","value":0.33,"profit":true},{"date":"2021-12-31","value":0.27,"profit":true},{"date":"2022-12-31","value":0.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(62.62K)(51.70K)45.75K86.85K(15.45M)[{"date":"2019-12-31","value":-72.1,"profit":false},{"date":"2020-12-31","value":-59.53,"profit":false},{"date":"2021-12-31","value":52.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17791.87,"profit":false}]
Gross Margin(Infinity%)(Infinity%)52.59%66.04%(41040.42%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":79.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-62146.56,"profit":false}]
Operating Expenses15.88M26.64M15.86M14.55M5.45M[{"date":"2019-12-31","value":59.6,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":59.52,"profit":true},{"date":"2022-12-31","value":54.62,"profit":true},{"date":"2023-12-31","value":20.46,"profit":true}]
Operating Income(15.88M)(26.64M)(15.77M)(14.42M)(20.90M)[{"date":"2019-12-31","value":-1587756900,"profit":false},{"date":"2020-12-31","value":-2664145600,"profit":false},{"date":"2021-12-31","value":-1577101800,"profit":false},{"date":"2022-12-31","value":-1441562800,"profit":false},{"date":"2023-12-31","value":-2090490300,"profit":false}]
Total Non-Operating Income/Expense624.28K289.37K119.50K248.04K463.75K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":46.35,"profit":true},{"date":"2021-12-31","value":19.14,"profit":true},{"date":"2022-12-31","value":39.73,"profit":true},{"date":"2023-12-31","value":74.29,"profit":true}]
Pre-Tax Income(15.57M)(26.43M)(15.71M)(14.29M)(20.66M)[{"date":"2019-12-31","value":-1556600300,"profit":false},{"date":"2020-12-31","value":-2643069900,"profit":false},{"date":"2021-12-31","value":-1571161400,"profit":false},{"date":"2022-12-31","value":-1428838900,"profit":false},{"date":"2023-12-31","value":-2065573700,"profit":false}]
Income Taxes7.76K12.48K16.43K(127.24K)(1.00)[{"date":"2019-12-31","value":47.22,"profit":true},{"date":"2020-12-31","value":75.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-774.62,"profit":false},{"date":"2023-12-31","value":-0.01,"profit":false}]
Income After Taxes(15.57M)(26.44M)(15.73M)(14.16M)(20.66M)[{"date":"2019-12-31","value":-1557375900,"profit":false},{"date":"2020-12-31","value":-2644317900,"profit":false},{"date":"2021-12-31","value":-1572804000,"profit":false},{"date":"2022-12-31","value":-1416115000,"profit":false},{"date":"2023-12-31","value":-2065573600,"profit":false}]
Income From Continuous Operations(15.57M)(26.43M)(15.71M)(14.29M)(10.15M)[{"date":"2019-12-31","value":-1556600300,"profit":false},{"date":"2020-12-31","value":-2643069900,"profit":false},{"date":"2021-12-31","value":-1571161400,"profit":false},{"date":"2022-12-31","value":-1428838900,"profit":false},{"date":"2023-12-31","value":-1014604800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(15.57M)(26.44M)(15.73M)(14.16M)(20.66M)[{"date":"2019-12-31","value":-1557375900,"profit":false},{"date":"2020-12-31","value":-2644317900,"profit":false},{"date":"2021-12-31","value":-1572804000,"profit":false},{"date":"2022-12-31","value":-1416115000,"profit":false},{"date":"2023-12-31","value":-2065573700,"profit":false}]
EPS (Diluted)(22.20)(28.80)(8.40)(7.71)(6.65)[{"date":"2019-12-31","value":-2220,"profit":false},{"date":"2020-12-31","value":-2880,"profit":false},{"date":"2021-12-31","value":-840,"profit":false},{"date":"2022-12-31","value":-771.01,"profit":false},{"date":"2023-12-31","value":-664.87,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OGEN
Cash Ratio 1.48
Current Ratio 1.93

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OGEN
ROA (LTM) -219.89%
ROE (LTM) -454.72%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OGEN
Debt Ratio Lower is generally better. Negative is bad. 0.41
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.59

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OGEN
Trailing PE NM
Forward PE NM
P/S (TTM) 578.50
P/B 2.83
Price/FCF NM
EV/R 105.83
EV/Ebitda 0.21
PEG NM

FAQs

What is Oragenics Inc share price today?

Oragenics Inc (OGEN) share price today is $0.343

Can Indians buy Oragenics Inc shares?

Yes, Indians can buy shares of Oragenics Inc (OGEN) on Vested. To buy Oragenics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OGEN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Oragenics Inc be purchased?

Yes, you can purchase fractional shares of Oragenics Inc (OGEN) via the Vested app. You can start investing in Oragenics Inc (OGEN) with a minimum investment of $1.

How to invest in Oragenics Inc shares from India?

You can invest in shares of Oragenics Inc (OGEN) via Vested in three simple steps:

  • Click on Sign Up or Invest in OGEN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Oragenics Inc shares
What is Oragenics Inc 52-week high and low stock price?

The 52-week high price of Oragenics Inc (OGEN) is $6.22. The 52-week low price of Oragenics Inc (OGEN) is $0.25.

What is Oragenics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Oragenics Inc (OGEN) is

What is Oragenics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Oragenics Inc (OGEN) is 2.83

What is Oragenics Inc dividend yield?

The dividend yield of Oragenics Inc (OGEN) is 0.00%

What is the Market Cap of Oragenics Inc?

The market capitalization of Oragenics Inc (OGEN) is $4.32M

What is Oragenics Inc’s stock symbol?

The stock symbol (or ticker) of Oragenics Inc is OGEN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top